Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 437 results for "biocon"

Biocon dips marginally as Syngene plans for IPO
India Infoline

Biocon to sell 10% stake in IVFA-backed R&D arm Syngene throug...

Biopharmaceutical major Biocon Ltd's research and development arm Syngene International Ltd has filed draft red herring prospectus (DRHP) with securities market regulator SEBI to float its initial public offer (IPO). The proposed public issue ... VC Circle, 3 days ago
Biocon dips marginally as Syngene plans for IPO India Infoline, 3 days ago

111 images for biocon

NDTV Profit, 35 minutes ago
IBN Live, 2 days ago
India Infoline, 3 days ago
Sify, 3 days ago
Sify, 3 days ago
Times of India, 4 days ago
Money Control, 3 days ago
First, 3 days ago, 4 hours ago, 4 minutes ago
Business Standard

Biocon subsidiary Syngene to float public issue

Pharma major Biocon Ltd, today said it has filed papers with the market regulator for floating a public issue for its R&D subsidiary, Syngene International Ltd. ''Syngene International Ltd, a subsidiary of the company has proposed public issue of ...
 NetIndia123.com3 days ago Biocon,TCS and PVR to see some action today  Indian-Commodity3 days ago Biocon gains after its subsidary Syngene files prospectus for IPO  Capital Market3 days ago Biocon subsidiary Syngene International files DRHP  Money Control3 days ago

Biocon plans to list its subsidiary Syngene with stock exchanges in July

Biocon is all set to get its subsidiary Syngene listed with the stock exchanges in July. In this regard, the company has filed the draft red herring prospectus on April 22 with the market regulator, Securities and Exchange Board of India (SEBI). ...
 Indian-Commodity3 days ago Biocon plans India listing for Syngene in R&D funding move  Fierce BioMarkers2 days ago Biocon arm Syngene files papers for ₹1,000-cr IPO  Hindu Business Line4 days ago Syngene dragged too far as value proposition; avoid Biocon: Prakash Diwan  Economic Times3 weeks ago

Update: Biocon Unit Sygene Files For IPO

Syngene, the research and development unit of biopharma firm Biocon, is going public through an offer for sale by its parent Biocon. Biocon is selling 22 million equity shares or 10% of the paid up capital in the company. Axis Capital, Credit ...
 Deal Curry3 days ago BUZZ-India's Biocon gains on unit's IPO plans  Reuters India3 days ago CORRECTED-BUZZ-India's Biocon gains on unit's IPO plans  Reuters India2 days ago Biocon gains on unit's IPO plans  Sify3 days ago
NDTV Profit

Biocon subsidiary files IPO

This page uses frames, but your browser doesn't
 Capital Market3 days ago Biocon Strengthens its Presence in Mexico  Process Worldwide1 week ago Biocon receives approval for insulin therapy with PiSA Farmaceutica in Mexico  Individual.com1 week ago Biocon's partner PiSA Farmaceutica gets Mexican approval for insulin glargine  PharmaBiz2 weeks ago

Biocon unit, Nuziveedu Seeds file draft IPO papers with Sebi [Mint, New Delhi]

April 23--MUMBAI -- Blackstone Group-backed Nuziveedu Seeds Ltd and Biocon Ltd Nuziveedu is looking to raise up to Rs.700 crore through the sale, said a merchant banker involved in the process. He declined to be named. The firm has hired JM ...
 BusinessWeek3 days ago
Business Standard

HDFC Bank, Cairn India, Biocon to be in Focus Today

The Indian benchmark indices, Sensex and Nifty are likely to open higher in trades on Thursday. The SGX Nifty at 8:05 a.m. was indicating a positive start for the Indian market as it was up 24 points or 0.3 per cent at 8,485 levels. Other Asian ...
 NDTV Profit3 days ago Market Watch: 15 stocks to watch in trade on Thursday  Business Standard3 days ago Indian Shares Poised To Open Higher  RTTNews.com3 days ago Green Nifty opening seen on positive global cues  Moneycontrol.com3 days ago

View: New land bill is not a zero-sum game

A pioneer of the biotechnology industry in India and the head of country's leading biotechnology enterprise, Biocon, Ms. Kiran Mazumdar-Shaw is a highly respected businesswoman. Ms. Shaw, a first generation entrepreneur, has made her country proud ...
 Economic Times4 days ago

Bullish on Biocon and Indraprastha Medical: G Chokkalingam, Equinomics Research & Advisory

Indraprastha Medical has already corrected about 30% from the peak within few months and secondly, it is a solid consistent growing company. In an interview with ET Now, G Chokkalingam, Founder, Equinomics Research & Advisory pvt Ltd., shares his views on ...
 Economic Times4 days ago
India Infoline

Emergency Responders on the Road: Paras Hospitals, Gurgaon conducts Basic Life Support Training for City's Auto-Drivers

Previous story: Leading pharma companies such as Cipla, Ranbaxy and Biocon adopt Cirrius PharmaCRM platform on Microsoft Azure to streamline medical engagements Next story: Harley Owners Group® take Aurangabad by storm for the 4th Western ...
 APN News5 days ago Cipla, Ranbaxy and Biocon adopt Cirrius PharmaCRM platform  India Infoline5 days ago Leading pharma companies such as Cipla, Ranbaxy and Biocon adopt Cirrius PharmaCRM platform on Microsoft Azure to streamline medical engagements  APN News5 days ago Cipla, Ranbaxy & Biocon Adopt Platform On Microsoft Azure  Businessworld India5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon
Get updated on latest news & your favorite topics right in your inbox!
More     Less